After the U.S. Food and Drug Administration recalled thousands of bottles of antidepressants it said contained high levels of a cancer-causing chemical, the federal agency has now upgraded the level ...

The Food and Drug Administration approved Revuforj from Syndax (SNDX) Pharmaceuticals, a menin inhibitor, for relapsed or refractory acute ...

Pharmaceuticals announced that the U.S. FDA has approved Revuforj as the first and only menin inhibitor for the treatment of ...

The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...

Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...

Researchers discovered an unexpected link between zinc deficiency, the pro-inflammatory cytokine interleukin-13 (IL-13), and Acinetobacter baumannii lung infection and demonstrated that blocking IL-13 ...

Danziten, a new formulation of nilotinib, may improve treatment adherence in patients with Philadelphia chromosome-positive ...

The FDA spent more than 15 years crafting the guidelines, which are designed to do away with industry practices that downplay ...

Research that was carried out by Baylor College of Medicine and Texas Children's Hospital doctors has led to the U.S. Food ...

Any changes Robert F. Kennedy Jr. wants to make will come up against a pharmaceutical industry that pays much of the U.S.

The FDA has approved the investigational new drug application of AS1986NS for prostate cancer detection and treatment.